纳普 (达维尼提德):神经保护性ADNP候选药物透细胞核,解释类机制

Maram Ganaiem1, Nina D Gildor1, Shula Shazman2,3

  • 1The Elton Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Sagol School of Neuroscience and Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv 6997801, Israel.

Cells
|September 28, 2023
PubMed
概括

候选药物NAP (davunetide) 通过与微管相互作用,纠正突变活动依赖神经保护蛋白 (ADNP) 细胞中的异常细胞结构. 这种机制解释了NAP.